Novonesis (Novozymes A/S)
19.8.2026 17:39:40 CEST | Globenewswire | Press release
Increased outlook for 2026
Increased outlook for 2026
Novonesis increases its full year 2026 organic sales growth outlook from 5-7% to now 7-8% based on a stronger performance so far in the year and the expectations for the rest of the year. Following the stronger sales growth outlook, the adjusted EBITDA margin is now expected to be at the higher end of the 37-38% range.
The H1 2026 announcement will be announced on August 19, 2026.
Publication of inside information pursuant to Market Abuse Regulation, Article 17.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
GN Store Nord A/S19.8.2026 18:55:00 CEST | Press release
Interim Report Q2 2026: Successful reception of Evolve3 headsets and gross margin improvement boding well for strong H2 2026
GN Store Nord A/S19.8.2026 18:43:04 CEST | Press release
Financial guidance 2026: Upgrading adjusted EBITA margin, while narrowing organic revenue growth guidance
Novonesis (Novozymes A/S)19.8.2026 18:25:57 CEST | Press release
H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook
Yacht Club de Monaco19.8.2026 18:07:17 CEST | Press release
21st Palermo-Montecarlo 2026 (18-23 August)
Novonesis (Novozymes A/S)19.8.2026 17:41:58 CEST | Press release
Interim report H1 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom